BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 36474108)

  • 21. Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers.
    Malani R; Bhatia A; Warner AB; Yang JT
    Semin Neurol; 2023 Dec; 43(6):859-866. PubMed ID: 37989214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment modalities for leptomeningeal metastases.
    Shapiro WR; Johanson CE; Boogerd W
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S46-54. PubMed ID: 19660683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptomeningeal metastasis from systemic cancer: Review and update on management.
    Wang N; Bertalan MS; Brastianos PK
    Cancer; 2018 Jan; 124(1):21-35. PubMed ID: 29165794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leptomeningeal carcinomatosis: easy to miss.
    Sekhar A; Corbo B; Das K; Biswas S
    J R Coll Physicians Edinb; 2017 Dec; 47(4):351-352. PubMed ID: 29537406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases.
    Pierret T; Giaj-Levra N; Toffart AC; Alongi F; Moro-Sibilot D; Gobbini E
    Front Oncol; 2022; 12():787080. PubMed ID: 35494085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis.
    Ruotolo R; Maffei E; Sabbatino F; Serio B; Zeppa P; Caputo A
    Diagn Cytopathol; 2023 Dec; 51(12):751-757. PubMed ID: 37638606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of metastatic leptomeningeal carcinomatosis from early gastric carcinoma.
    Park KK; Yang SI; Seo KW; Kim YO; Yoon KY
    World J Surg Oncol; 2012 May; 10():74. PubMed ID: 22553956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.
    Lee YC; Hsieh CC; Chuang JP; Li CY
    Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies.
    Bhambhvani HP; Rodrigues AJ; Umeh-Garcia MC; Hayden Gephart M
    Neurosurg Clin N Am; 2020 Oct; 31(4):613-625. PubMed ID: 32921356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease.
    Hochmair M
    Target Oncol; 2018 Jun; 13(3):269-285. PubMed ID: 29700687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
    Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
    J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era.
    Remon J; Le Rhun E; Besse B
    Cancer Treat Rev; 2017 Feb; 53():128-137. PubMed ID: 28110254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asynchronous leptomeningeal carcinomatosis from pancreatic cancer: a case report and review of the literature.
    Hong CS; Kurt H; Elder JB
    Clin J Gastroenterol; 2014 Oct; 7(5):434-40. PubMed ID: 26184025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptomeningeal metastases: the future is now.
    Lukas RV; Thakkar JP; Cristofanilli M; Chandra S; Sosman JA; Patel JD; Kumthekar P; Stupp R; Lesniak MS
    J Neurooncol; 2022 Feb; 156(3):443-452. PubMed ID: 35048267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel approaches to treatment of leptomeningeal metastases.
    Primdahl D; Cohen-Nowak A; Kumthekar P
    Curr Opin Neurol; 2023 Dec; 36(6):592-602. PubMed ID: 37865856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.
    Kak M; Nanda R; Ramsdale EE; Lukas RV
    J Clin Neurosci; 2015 Apr; 22(4):632-7. PubMed ID: 25677875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptomeningeal Carcinomatosis After Neoplastic Cerebral Aneurysm Rupture.
    Koga M; Aoki T; Negoto T; Makizono T; Sugi K; Fujimori K; Kajiwara S; Komaki S; Yoshitomi M; Sugita Y; Morioka M
    World Neurosurg; 2019 Jun; 126():281-284. PubMed ID: 30822576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PET.
    Carra BJ; Clemenshaw MN
    J Nucl Med Technol; 2015 Sep; 43(3):227-8. PubMed ID: 25655343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
    Yang H; Wen L; Pan Y; Shan C; Hong W; Wang H; Zhou C; Cai L; Zhou C
    BMC Cancer; 2022 May; 22(1):580. PubMed ID: 35614407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.